JP2011525501A5 - - Google Patents

Download PDF

Info

Publication number
JP2011525501A5
JP2011525501A5 JP2011515137A JP2011515137A JP2011525501A5 JP 2011525501 A5 JP2011525501 A5 JP 2011525501A5 JP 2011515137 A JP2011515137 A JP 2011515137A JP 2011515137 A JP2011515137 A JP 2011515137A JP 2011525501 A5 JP2011525501 A5 JP 2011525501A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
slag
tablet
polyallylamine polymer
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011515137A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011525501A (ja
Filing date
Publication date
Priority claimed from DE102008030046A external-priority patent/DE102008030046A1/de
Application filed filed Critical
Publication of JP2011525501A publication Critical patent/JP2011525501A/ja
Publication of JP2011525501A5 publication Critical patent/JP2011525501A5/ja
Pending legal-status Critical Current

Links

JP2011515137A 2008-06-25 2009-03-20 緻密化ポリアリルアミンポリマー Pending JP2011525501A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102088030046.2 2008-06-25
DE102008030046A DE102008030046A1 (de) 2008-06-25 2008-06-25 Kompaktiertes Polyallylamin-Polymer
PCT/EP2009/002071 WO2009156014A1 (de) 2008-06-25 2009-03-20 Kompaktiertes polyallylamin-polymer enthaltende tabletten und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
JP2011525501A JP2011525501A (ja) 2011-09-22
JP2011525501A5 true JP2011525501A5 (cg-RX-API-DMAC7.html) 2012-05-24

Family

ID=40600236

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011515137A Pending JP2011525501A (ja) 2008-06-25 2009-03-20 緻密化ポリアリルアミンポリマー

Country Status (6)

Country Link
US (1) US20110189121A1 (cg-RX-API-DMAC7.html)
EP (1) EP2309977A1 (cg-RX-API-DMAC7.html)
JP (1) JP2011525501A (cg-RX-API-DMAC7.html)
CA (1) CA2731853A1 (cg-RX-API-DMAC7.html)
DE (1) DE102008030046A1 (cg-RX-API-DMAC7.html)
WO (1) WO2009156014A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7964182B2 (en) 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
BRPI1006969A2 (pt) * 2009-01-22 2016-04-12 Usv Ltd composições farmacêuticas compreendendo polímero de ligação a fosfato
DK2490675T3 (en) * 2009-10-22 2019-04-29 Synthon Bv Pharmaceutical compositions with sevelamer
KR20240152425A (ko) 2013-06-05 2024-10-21 트리시다, 인크. 경구 투여를 위한 양성자-결합 중합체
WO2015075065A1 (en) 2013-11-20 2015-05-28 Sanovel Ilac Sanayi Ve Ticaret A.S. Tablet formulation of colesevelam
EP3718551A1 (en) 2014-12-10 2020-10-07 Tricida Inc. Proton-binding polymers for oral administration
WO2016135065A1 (en) 2015-02-23 2016-09-01 Amneal Pharmaceuticals Company Gmbh Process for granulating sevelamer carbonate
US10245284B2 (en) 2015-08-19 2019-04-02 Alpex Pharma S.A. Granular composition for oral administration
CN116211887A (zh) 2016-05-06 2023-06-06 特里赛达公司 用于治疗酸碱失衡的组合物
IL273960B2 (en) 2017-11-03 2025-08-01 Tricida Inc Nonabsorable compositions for use in treating or preventing metabolic acidosis
CN112972407A (zh) * 2019-12-18 2021-06-18 南京恒生制药有限公司 一种碳酸司维拉姆片剂组合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59202679D1 (de) * 1991-02-11 1995-08-03 Paul Gerteis VORRICHTUNG ZUM KONTINUIERLICHEN MECHANISCHEN UMFORMEN VON TEILCHENFöRMIGEN STOFFEN.
US5496545A (en) 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
TW474813B (en) 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
TW592727B (en) 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
DE19758100B4 (de) * 1997-12-18 2006-05-04 Lichtwer Pharma Ag Verfahren zum Herstellen von Pflanzenextrakt enthaltenden pharmazeutischen Formulierungen
TW568788B (en) 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
JP3363143B2 (ja) * 1998-10-12 2003-01-08 中外製薬株式会社 リン酸結合性ポリマー粒子
DE60017285T2 (de) * 1999-10-19 2005-12-08 Genzyme Corp., Cambridge Direktkomprimierter tablettenkern auf polymerbasis
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
US7193006B2 (en) * 2002-12-06 2007-03-20 Nippon Shokubai Co., Ltd. Process for continuous production of water-absorbent resin product
WO2005065291A2 (en) * 2003-12-31 2005-07-21 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
US7985418B2 (en) * 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
UA100966C2 (ru) * 2005-04-08 2013-02-25 Эбботт Леборетриз Фармацевтическая композиция на основе 2-[4-(4-хлорбензоил)фенокси]-2-метилпропионовой кислоты и ее солей

Similar Documents

Publication Publication Date Title
JP2011525501A5 (cg-RX-API-DMAC7.html)
Sekar et al. Immediate release tablets of telmisartan using superdisintegrant-formulation, evaluation and stability studies
KR101500769B1 (ko) 위액 내성인 활성 물질 매트릭스를 포함하는 펠렛
CA2955495C (en) High dosage strength tablets of rucaparib
JP2013521226A5 (cg-RX-API-DMAC7.html)
HRP20160179T1 (hr) Formulacije apiksabana
JP5534004B2 (ja) 口腔内崩壊錠
JP2011006446A (ja) アトルバスタチン経口投与用粒子状医薬組成物
JP2015166379A5 (cg-RX-API-DMAC7.html)
HRP20161262T1 (hr) Tablete ulipristal acetata
JP2006528221A5 (cg-RX-API-DMAC7.html)
JP2012509329A5 (cg-RX-API-DMAC7.html)
EP3606511A1 (en) Pharmaceutical composition comprising lenvatinib mesylate
CN101579324B (zh) 一种奥美拉唑肠溶速释片的制备方法
JP5944378B2 (ja) アカルボースを含む口腔内崩壊錠
JP5614445B2 (ja) 経口投与用粒子状医薬組成物
HRP20191217T1 (hr) Čvrsti farmaceutski sastav citizina i postupak pripreme istog
Kuno et al. Effect of preparation method on properties of orally disintegrating tablets made by phase transition
CA2797551A1 (en) Melt-granulated fingolimod
CN102526748B (zh) 含有缬沙坦、氢氯噻嗪和苯磺酸氨氯地平的口服片剂
JP6707126B2 (ja) 経口投与用球状吸着炭を含む錠剤及びその製造方法
WO2014154643A1 (en) Extended release formulations of metformin
RU2015129714A (ru) Композиция в форме таблеток, содержащая гидрохлорид цинакалцета
JP2010530890A5 (cg-RX-API-DMAC7.html)
CN102552170A (zh) 一种以苯磺酸普拉格雷为活性成分的固体制剂